Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q Codeletion

Clinical trial NCT01534845 · UNKNOWN

Trial details

NCT number: NCT01534845
Sponsor: Jong Hoon Kim
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic Glioma of Brain Loss of Chromosomes 1p/19q

Start date: 2012-03-01
Primary completion: 2015-02-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.